Kyverna Therapeutics, Inc.
KYTX
Revenue
0.00
0.000.00%
-Assets
304.65M
▼-34.55M▼-10.19%
3 Months ChangeLiabilities
38.06M
▲1.57M▲4.31%
3 Months ChangeFree Cash Flow
-26.07M
▼-14.58M▼-126.95%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-21
Form 8-K
ID: 0001213900-24-089095
2024-09-16
Form 8-K
ID: 0001213900-24-078736
2024-08-12
Form 10-Q
ID: 0000950170-24-095462
2024-08-12
Form 8-K
ID: 0000950170-24-095433
2024-07-15
Form 8-K
ID: 0000950170-24-083570
2024-06-14
Form 8-K
ID: 0000950170-24-073312
2024-05-14
Form 10-Q
ID: 0000950170-24-059628
2024-05-14
Form 8-K
ID: 0000950170-24-059613
2024-03-26
Form 8-K
ID: 0000950170-24-036410
2024-02-12
Form 8-K
ID: 0001193125-24-032161